MMD Stock Overview
Milestone Medical, Inc. develops, manufactures, commercializes, and markets intra-articular and epidural drug delivery systems in the United States and Europe.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Milestone Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł1.58 |
| 52 Week High | zł2.74 |
| 52 Week Low | zł1.43 |
| Beta | 0.83 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -18.97% |
| 3 Year Change | -84.20% |
| 5 Year Change | -73.67% |
| Change since IPO | -78.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| MMD | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | 0% | -4.5% | -0.3% |
| 1Y | -19.0% | -9.7% | 22.6% |
Return vs Industry: MMD underperformed the Polish Medical Equipment industry which returned -11.8% over the past year.
Return vs Market: MMD underperformed the Polish Market which returned 35.1% over the past year.
Price Volatility
| MMD volatility | |
|---|---|
| MMD Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PL Market | 9.9% |
| 10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: MMD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MMD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 12 | Arjan Haverhals | medicalmilestone.com |
Milestone Medical, Inc. develops, manufactures, commercializes, and markets intra-articular and epidural drug delivery systems in the United States and Europe. The company’s products are based on computer-controlled injection and drug delivery technology. Its products include dynamic pressure sensing system, a patented computer-controlled injection system that measures the density of body tissue and helps clinician know the location of a hypodermic needle during an injection; and intra-articular injection instrument that is used to inject into various joints in treatment of arthritis and other joint conditions.
Milestone Medical, Inc. Fundamentals Summary
| MMD fundamental statistics | |
|---|---|
| Market cap | zł34.76m |
| Earnings (TTM) | -zł13.92m |
| Revenue (TTM) | zł29.24k |
1,189x
P/S Ratio-2.5x
P/E RatioIs MMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MMD income statement (TTM) | |
|---|---|
| Revenue | US$7.40k |
| Cost of Revenue | US$254.35k |
| Gross Profit | -US$246.95k |
| Other Expenses | US$3.28m |
| Earnings | -US$3.52m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.16 |
| Gross Margin | -3,337.15% |
| Net Profit Margin | -47,612.84% |
| Debt/Equity Ratio | -97.2% |
How did MMD perform over the long term?
See historical performance and comparison